417 related articles for article (PubMed ID: 25542050)
1. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
Cantón R; Canut A; Morosini MI; Oliver A
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
[TBL] [Abstract][Full Text] [Related]
2. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
[TBL] [Abstract][Full Text] [Related]
3. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.
Vading M; Samuelsen Ø; Haldorsen B; Sundsfjord AS; Giske CG
Clin Microbiol Infect; 2011 May; 17(5):668-74. PubMed ID: 20649801
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
[TBL] [Abstract][Full Text] [Related]
5. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
6. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
7. Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
Robert J; Pantel A; Merens A; Meiller E; Lavigne JP; Nicolas-Chanoine MH;
BMC Infect Dis; 2017 Jan; 17(1):78. PubMed ID: 28095794
[TBL] [Abstract][Full Text] [Related]
8. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs.
Patel TS; Nagel JL
J Clin Microbiol; 2015 Jan; 53(1):201-5. PubMed ID: 25378572
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?
Humphries RM; Hindler JA; Epson E; Horwich-Scholefield S; Miller LG; Mendez J; Martinez JB; Sinkowitz J; Sinkowtiz D; Hershey C; Marquez P; Bhaurla S; Moran M; Pandes L; Terashita D; McKinnell JA
Clin Infect Dis; 2018 Mar; 66(7):1061-1067. PubMed ID: 29099915
[TBL] [Abstract][Full Text] [Related]
11. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
[TBL] [Abstract][Full Text] [Related]
12. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
[TBL] [Abstract][Full Text] [Related]
13. What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
Fattouh R; Tijet N; McGeer A; Poutanen SM; Melano RG; Patel SN
Antimicrob Agents Chemother; 2015 Dec; 60(3):1556-9. PubMed ID: 26711746
[TBL] [Abstract][Full Text] [Related]
14. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
[TBL] [Abstract][Full Text] [Related]
15. Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
Miller S; Humphries RM
Expert Rev Anti Infect Ther; 2016 Aug; 14(8):705-17. PubMed ID: 27348447
[TBL] [Abstract][Full Text] [Related]
16. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
Kahlmeter G
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
[TBL] [Abstract][Full Text] [Related]
17. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
Hombach M; Mouttet B; Bloemberg GV
J Antimicrob Chemother; 2013 Sep; 68(9):2092-8. PubMed ID: 23633681
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Deshpande LM; Jones RN; Fritsche TR; Sader HS
Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
[TBL] [Abstract][Full Text] [Related]
19. Routinely available antimicrobial susceptibility information can be used to increase the efficiency of screening for carbapenemase-producing
Ong DSY; Altorf-van der Kuil W; Vlek ALM; Schouls LM; Schoffelen AF
J Med Microbiol; 2020 Oct; 69(10):1235-1239. PubMed ID: 32924918
[No Abstract] [Full Text] [Related]
20. Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria.
Asín E; Isla A; Canut A; Rodríguez Gascón A
Int J Antimicrob Agents; 2012 Oct; 40(4):313-22. PubMed ID: 22921422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
